FDA NDC Directory · JSON-LD · Markdown

Bromocriptine mesylate

NDC 65841-654 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA078899
Dosage form / routeCAPSULE · ORAL
Active ingredientsBROMOCRIPTINE MESYLATE (5 mg/1)
Marketing started20090123
Package count2

External sources

Source: openFDA. Public-domain (CC0).